BBC News anchor Maryam Moshiri has revealed she has been diagnosed with incurable blood cancer. The anchor, who joined the BBC in 2003, has covered events ranging from the Pope’s funeral to the Iran war since being diagnosed with Polycythaemia vera (PV) two years ago. Moshiri went public with her diagnosis Monday in an interview
Watt, A. C. et al. Nature 657, 517–524 (2026). Article Google Scholar Osborne, C. K. & Schiff, R. Ann. Rev. Med. 62, 233–247 (2011). Article PubMed Google Scholar Morrison, L., Loibl, S. & Turner, N. C. Nature Rev. Clin. Oncol. 21, 89–105 (2024). Article PubMed Google Scholar Knudsen, E. S., Witkiewicz, A. K. & Kabraji,
Studies in mice suggest that psilocybin, one of the psychoactive compounds in magic mushrooms, could prevent the chemotherapy side effect called neuropathy.Credit: Victor de Schwanberg/SPL For many cancer survivors, the triumph of remission is undercut by a debilitating side effect: hands and feet that feel as though they are constantly burning, prickling with needles or
Skin cancer cells viewed under a microscope. Such images can reveal how the cancer spreads.Credit: NCI Center for Cancer Research/NCI/SPL The announcement on 19 August that people with melanoma who received a personalized vaccine lived longer without a cancer recurrence than those who didn’t have the vaccine is a sensation for the field. The results
FILE – A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md., Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File) Manuel Balce Ceneta/AP hide caption toggle caption Manuel Balce Ceneta/AP The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering
The Food and Drug Administration on Wednesday approved Rasonque, a once-daily pill developed by Revolution Medicines to block several forms of the RAS protein — the mutation that drives tumor growth in most pancreatic cancers, and in roughly a quarter of all human cancers overall. For investors like Dr. Danish Nagda, an early shareholder in